Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Lilit Karapetyan, MD)
Study leads
Lilit Karapetyan, MD
Principal Investigator
Moffitt Cancer Center